To: Administrator Seema Verma
"These waivers and enforcement flexibilities are prudent to protect people with diabetes who are at high-risk for the COVID-19 virus and to ensure they have the diabetes devices they need to manage their disease during this public health crisis. We believe -- and hope that you agree -- that these waivers should apply to all people with diabetes, regardless of respiratory disease status, as part of the mitigation efforts to prevent virus exposure and to preserve capacity and resources within the healthcare system during this pandemic."
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.